Sector | Finance | Compare with Sector peers |
Industry | Finance - Investment | Compare with Industry peers |
Website | http://www.amerisebiosciencesltd.shop | |
Market Cap | 4.16 Cr. | |
Enterprise Value(EV) | Cr. | - |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -0.03 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-12 |
Industry PE | 15.73 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 0.81 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 0.78 | Calculated using Price: 0.63 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 6.61 Cr. | 66,069,000 Shares |
FaceValue | 1 | |
About Amerise Biosciences Ltd. | ||
The company is engaged in commodity trading and in financial year (FY) 2007 it entered into the trading of castor seeds. |
1 Day |
|
|
1 Week |
|
+1.61% |
1 Month |
|
-8.70% |
3 Month |
|
-16.00% |
6 Month |
|
+16.67% |
1 Year |
|
-18.18% |
2 Year |
|
-48.36% |
5 Year |
|
-26.74% |
10 Year |
|
-89.50% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | -0.72 | -0.43 | -15.5 | -0.38 | 0.07 | -2.71 | -6.41 | 10.24 | -2.13 | |
Return on Capital Employed (%) | -0.68 | -0.43 | -15.5 | -0.38 | 0.07 | -2.7 | -6.41 | 10.17 | -2.1 | |
Return on Assets (%) | -0.69 | -0.43 | -15.43 | -0.38 | 0.07 | -2.56 | -5.79 | 6.24 | -1.35 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 7 | 7 | 6 | 6 | 6 | 5 | 5 | 6 | 6 | 5 | |
Non Curr. Liab. | 0 | 0 | 0 | ||||||||
Curr. Liab. | 0 | 0 | 0 | 0 | 1 | 1 | 6 | 0 | 0 | ||
Minority Int. | |||||||||||
Equity & Liab. | 7 | 7 | 6 | 6 | 6 | 6 | 6 | 12 | 6 | 6 | |
Non Curr. Assets | 3 | 6 | 3 | 3 | 1 | 6 | 6 | 6 | 6 | 6 | |
Curr. Assets | 4 | 0 | 3 | 3 | 4 | 0 | 0 | 6 | 0 | 0 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 7 | 7 | 6 | 6 | 6 | 6 | 6 | 12 | 6 | 6 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 1 | 9 | |||||||||
Other Income | 1 | 0 | |||||||||
Total Income | 1 | 10 | 0 | ||||||||
Total Expenditure | 0 | 0 | -1 | 0 | -1 | 0 | 0 | -9 | 0 | 0 | |
PBIDT | 0 | 0 | -1 | 0 | 0 | 0 | 1 | 0 | 0 | ||
Interest | |||||||||||
Depreciation | |||||||||||
Taxation | |||||||||||
Exceptional Items | |||||||||||
PAT | 0 | 0 | -1 | 0 | 0 | 0 | 1 | 0 | 0 | ||
Adjusted EPS | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 3 | 0 | 1 | -4 | 0 | -2 | 5 | 0 | 0 | 0 | |
Cash Fr. Inv. | -1 | 0 | -1 | 4 | 0 | 2 | -5 | 0 | 0 | 0 | |
Cash Fr. Finan. | -2 | -1 | 0 | 0 | |||||||
Net Change | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Wed, 24 Apr 2024
Compliance Certificate Pursuant To Regulation 7(3) Of The SEDIListing Obligations And Disclosure Requirements) Reguiations 2015 For The Period From April 1 2023 To March 31 2024. PFA |
Fri, 29 Mar 2024
Closure of Trading Window Intimation of Closure of Trading Window for considering the Audited Financial Results of the company for Quarter and Year ended on 31st March 2024 |
Tue, 13 Feb 2024
Un-Audited Financial Result Quarter Ended On 31St December 2023 Pursuant To Regulation 33 Of The SEBI (LODR) Regulations 2015. PFA |
Thu, 25 Apr 2024 |
High Delivery Percentage |
Opening at High |
High Decrease in 1 Month |
High Decrease in 3 Months |
Close Below Last Month Low |